Fig. 3.

Most frequent first-line treatments among patients initiating treatment post-vitiligo diagnosis, 12-month follow-up. A All ages (N = 5845). B Among adolescent patients (N = 486). Patients initiating treatment are defined as those who did not receive any vitiligo-related treatments prior to diagnosis of vitiligo. Adolescents defined as those aged 12–17 years. CS corticosteroid, HTCS high-potency topical CS, MTCS medium-potency topical CS, LTCS low-potency topical CS, TCI topical calcineurin inhibitors